Jürgen Noeske
Jürgen Noeske has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Christopher Kuaban
2 shared publicationsC Kuaban
1 shared publication- Christelle Géneviève Jouego
Tuberculosis Reference Laboratory Bamenda, P.O Box 586, Bamenda, Northwest Region, Cameroon.
1 shared publication - Elisabeth Fon
Regional Tuberculosis Control Unit, Regional Delegation of Public Health, P.O. Box 106, Douala, Cameroon
1 shared publication - Jean-Louis Abena
Yaounde, Cameroon
1 shared publication Jean-Louis Abena Foe
National Tuberculosis Programme, Yaounde, Cameroon
1 shared publication
Latest Publications
- Open Access
- 22 January 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 57
Pediatric multi-drug resistant-tuberculosis and HIV co-infection in a resource—limited setting: a case report
Tuberculosis remains a major cause of morbidity and mortality worldwide, especially in developing countries. The diagnosis and treatment of multi-drug resistant tuberculosis (MDR-TB) in children remain a major limitation in this setting, largely due to difficulties in isolating Mycobacterium tuberculosis from pediatric specimens, management with toxic second line drugs, and practically the inexistence of contact tracing. In 2016, the World Health Organization (WHO) recommended a standardized 9-month regimen for adults and children in zones which are highly endemic for the human immunodeficiency virus (HIV). Herein, we present a case of pediatric MDR-TB/HIV co-infection highlighting the difficulties in treatment and the importance of contact tracing. A 6-year old male infant from the West Region of Cameroon infected with HIV who presented at a local health center with a 10 days history of productive cough associated with nocturnal fever and abdominal pains non responsive to broad spectrum antibiotics. A sputum sample analysis requested was smear positive for acid-fast bacilli, and he was initiated on quadritherapy for drug sensitive pulmonary tuberculosis. Since he was a household contact of the mother who was being managed in a referral hospital for MDR-TB at 1 month of treatment, and given his critical clinical situation, a gastric aspirate was repeated and sent for Xpert MTB/RIF to the Tuberculosis Reference Laboratory which was positive for a Rifampicin resistant strain of M. tuberculosis. The short 9 months regimen against MDR-TB was then initiated. During the course of his management, he developed minor side effects of the drugs which were managed symptomatically. Even though pediatric MDR-TB is difficult to confirm, it can be treated with favorable clinical outcomes using the short regimen recommended by the WHO. Experts involved in the control of tuberculosis over the national territory should consider adopting routine contact tracing for all cases of tuberculosis particularly amongst children.
- 22 January 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 57
Open AccessPediatric multi-drug resistant-tuberculosis and HIV co-infection in a resource—limited setting: a case report
Tuberculosis remains a major cause of morbidity and mortality worldwide, especially in developing countries. The diagnosis and treatment of multi-drug resistant tuberculosis (MDR-TB) in children remain a major limitation in this setting, largely due to difficulties in isolating Mycobacterium tuberculosis from pediatric specimens, management with toxic second line drugs, and practically the inexistence of contact tracing. In 2016, the World Health Organization (WHO) recommended a standardized 9-month regimen for adults and children in zones which are highly endemic for the human immunodeficiency virus (HIV). Herein, we present a case of pediatric MDR-TB/HIV co-infection highlighting the difficulties in treatment and the importance of contact tracing. A 6-year old male infant from the West Region of Cameroon infected with HIV who presented at a local health center with a 10 days history of productive cough associated with nocturnal fever and abdominal pains non responsive to broad spectrum antibiotics. A sputum sample analysis requested was smear positive for acid-fast bacilli, and he was initiated on quadritherapy for drug sensitive pulmonary tuberculosis. Since he was a household contact of the mother who was being managed in a referral hospital for MDR-TB at 1 month of treatment, and given his critical clinical situation, a gastric aspirate was repeated and sent for Xpert MTB/RIF to the Tuberculosis Reference Laboratory which was positive for a Rifampicin resistant strain of M. tuberculosis. The short 9 months regimen against MDR-TB was then initiated. During the course of his management, he developed minor side effects of the drugs which were managed symptomatically. Even though pediatric MDR-TB is difficult to confirm, it can be treated with favorable clinical outcomes using the short regimen recommended by the WHO. Experts involved in the control of tuberculosis over the national territory should consider adopting routine contact tracing for all cases of tuberculosis particularly amongst children.
- 1 April 2017
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 21 (4) , 471
Exclusion of the other: revival of an age-old political paradigm.
- 1 April 2017
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 21 (4) , 471
Exclusion of the other: revival of an age-old political paradigm.
- Open Access
- 31 January 2016
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 47 (2) , 684-686
Cameroon's MDR-TB treatment programme jeopardised by cross-border migration
MDR-TB treatment programme can be jeopardised by cross-border migration as seen in Cameroon http://ow.ly/WHbxw
- 31 January 2016
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 47 (2) , 684-686
Open AccessCameroon's MDR-TB treatment programme jeopardised by cross-border migration
MDR-TB treatment programme can be jeopardised by cross-border migration as seen in Cameroon http://ow.ly/WHbxw
- 1 September 2014
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 18 (9) , 1132
Private rights vs. public good: a matter for opinion polls?
- 1 September 2014
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 18 (9) , 1132
Private rights vs. public good: a matter for opinion polls?
- Open Access
- 21 March 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 160
Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon
The number of pulmonary tuberculosis (PTB) patients reported with resistance to first-line anti-tuberculosis drugs after a standardized retreatment regimen in Cameroon is increasing. Hence, the National Tuberculosis Control Program (NTP) implemented, in one of the ten Regions of the country, a pilot programme aimed at performing routine drug susceptibility testing (DST) for previously treated PTB cases. The objectives of the programme were to evaluate the feasibility of monitoring drug resistance among retreatment cases under programme conditions and to measure the presence and magnitude of anti-TB drug resistance in order to inform NTP policies.
- 21 March 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 160
Open AccessEarly results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon
The number of pulmonary tuberculosis (PTB) patients reported with resistance to first-line anti-tuberculosis drugs after a standardized retreatment regimen in Cameroon is increasing. Hence, the National Tuberculosis Control Program (NTP) implemented, in one of the ten Regions of the country, a pilot programme aimed at performing routine drug susceptibility testing (DST) for previously treated PTB cases. The objectives of the programme were to evaluate the feasibility of monitoring drug resistance among retreatment cases under programme conditions and to measure the presence and magnitude of anti-TB drug resistance in order to inform NTP policies.
- 1 February 2011
- Vol. 15 (2) , 223-7, i
Controlling tuberculosis in prisons against confinement conditions: a lost case? Experience from Cameroon.
Tuberculosis (TB) is recognised as a major public health problem in the prisons of sub-Saharan Africa. In Cameroon, the main prisons have created diagnostic and treatment units linked to the National Tuberculosis Programme (NTP). To assess the effectiveness of routine TB control activities in a prison population by determining the prevalence of undetected pulmonary tuberculosis (PTB). In 2009, a PTB case-finding survey was undertaken at the Central Prison of Yaounde (CPY), Cameroon. All prisoners with cough of ≥1 week's duration were screened by sputum smear microscopy. Smears were sent to the national reference laboratory for culture and drug susceptibility testing (DST). Voluntary testing for human immunodeficiency virus (HIV) was offered to all inmates. Among 3219 inmates screened, 40 (1.2%) identified with PTB had been missed by the prison TB control programme. Missed PTB was positively associated with severe crowding, low body mass index and previous TB treatment. Of the 40 inmates, four (10%) were TB-HIV co-infected. The DST of three inmates revealed resistance to anti-tuberculosis drugs. Despite a well-performing TB control programme in the CPY, the number of undetected PTB cases remains unacceptably high. It is doubtful whether TB transmission can be controlled under conditions of confinement, such as the CPY.
- 1 February 2011
- Vol. 15 (2) , 223-7, i
Controlling tuberculosis in prisons against confinement conditions: a lost case? Experience from Cameroon.
Tuberculosis (TB) is recognised as a major public health problem in the prisons of sub-Saharan Africa. In Cameroon, the main prisons have created diagnostic and treatment units linked to the National Tuberculosis Programme (NTP). To assess the effectiveness of routine TB control activities in a prison population by determining the prevalence of undetected pulmonary tuberculosis (PTB). In 2009, a PTB case-finding survey was undertaken at the Central Prison of Yaounde (CPY), Cameroon. All prisoners with cough of ≥1 week's duration were screened by sputum smear microscopy. Smears were sent to the national reference laboratory for culture and drug susceptibility testing (DST). Voluntary testing for human immunodeficiency virus (HIV) was offered to all inmates. Among 3219 inmates screened, 40 (1.2%) identified with PTB had been missed by the prison TB control programme. Missed PTB was positively associated with severe crowding, low body mass index and previous TB treatment. Of the 40 inmates, four (10%) were TB-HIV co-infected. The DST of three inmates revealed resistance to anti-tuberculosis drugs. Despite a well-performing TB control programme in the CPY, the number of undetected PTB cases remains unacceptably high. It is doubtful whether TB transmission can be controlled under conditions of confinement, such as the CPY.
- 1 March 2004
- Vol. 8 (3) , 346-51
Are smear-positive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon?
To assess whether the human immunodeficiency virus (HIV) seroprevalence rate in adults with smear-positive pulmonary tuberculosis (PTB) can serve as a sentinel group for the estimation of HIV prevalence in the general adult population in Cameroon. A systematic review of reported HIV seroprevalence rates in the general adult population and in adults aged 15 years and over with PTB in Cameroon, using indexed and non indexed articles, publications, and reports from 1989 to 2000. Reconstruction of the evolution of the HIV seroprevalence in the two populations was done, and the relationship between these was established by the regression equation and the calculation of the correlation coefficient r. During the period 1989-2000, the evolution of HIV seroprevalence in the general adult population and in adults with PTB showed a steady increase, with a strong linear relationship (r = 0.96, df 7, P < 0.01). Each percentage increase of HIV seroprevalence among PTB patients corresponded to an increase of seroprevalence of about 0.3% in the general population. HIV seroprevalence in PTB patients in Cameroon could serve as a 'sentinel' for HIV seroprevalence in the general population.
- 1 March 2004
- Vol. 8 (3) , 346-51
Are smear-positive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon?
To assess whether the human immunodeficiency virus (HIV) seroprevalence rate in adults with smear-positive pulmonary tuberculosis (PTB) can serve as a sentinel group for the estimation of HIV prevalence in the general adult population in Cameroon. A systematic review of reported HIV seroprevalence rates in the general adult population and in adults aged 15 years and over with PTB in Cameroon, using indexed and non indexed articles, publications, and reports from 1989 to 2000. Reconstruction of the evolution of the HIV seroprevalence in the two populations was done, and the relationship between these was established by the regression equation and the calculation of the correlation coefficient r. During the period 1989-2000, the evolution of HIV seroprevalence in the general adult population and in adults with PTB showed a steady increase, with a strong linear relationship (r = 0.96, df 7, P < 0.01). Each percentage increase of HIV seroprevalence among PTB patients corresponded to an increase of seroprevalence of about 0.3% in the general population. HIV seroprevalence in PTB patients in Cameroon could serve as a 'sentinel' for HIV seroprevalence in the general population.
- 1 July 2002
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 96 (4) , 429-433
Impact of resistance to anti-tuberculosis drugs on treatment outcome using World Health Organization standard regimens
We compared treatment outcome in 410 patients with drug-susceptible tuberculosis (DS-TB) and 150 patients with drug-resistant tuberculosis (DR-TB) am
- 1 July 2002
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 96 (4) , 429-433
Impact of resistance to anti-tuberculosis drugs on treatment outcome using World Health Organization standard regimens
We compared treatment outcome in 410 patients with drug-susceptible tuberculosis (DS-TB) and 150 patients with drug-resistant tuberculosis (DR-TB) am